Results of a feasibility study of I-124 girentuximab in metastatic clear cell renal cell carcinoma (m ccRCC).

被引：0
|
作者：
Keefe, Stephen Michael [1 ]
Rosen, Mark Alan [1 ]
Robinson, Janelle [1 ]
McGibney, Karen [1 ]
Marshall, Amy [1 ]
Mamtani, Ronac [1 ]
Vaughn, David J. [1 ]
O'Dwyer, Peter J. [1 ]
Haas, Naomi B. [1 ]
Pryma, Daniel A. [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.406
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
406
引用
收藏
页数：1
相关论文
共 50 条
  • [41] BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC)
    Pesta, Martin
    Travnicek, Ivan
    Kulda, Vlastimil
    Windrichova, Jindra
    Rezackova, Hana
    Houfkova, Katerina
    Macanova, Tereza
    Bendova, Barbora
    Nestorova, Andrea
    Hes, Ondrej
    Hora, Milan
    Topolcan, Ondrej
    Polivka, Jiri
    ANTICANCER RESEARCH, 2021, 41 (09) : 4463 - 4470
  • [42] Intraventricular metastatic clear cell renal carcinoma
    Sava, I.
    Sava, Anca
    Sapte, Elena
    Mihailov, Claudia
    Dumitrescu, Gabriela
    Poeata, I.
    Sava, Florina
    Haba, Danisia
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2013, 54 (02): : 447 - 450
  • [43] Metastatic periampullary clear cell renal carcinoma
    Jideh, Bilel
    Chen, Hank
    Weltman, Martin
    Chan, Calvin H. Y.
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : 1040 - 1041
  • [44] Indium-111-labeled Girentuximab ImmunoSPECT as a Diagnostic Tool in Clear Cell Renal Cell Carcinoma
    Muselaers, Constantijn H. J.
    Boerman, Otto C.
    Oosterwijk, Egbert
    Langenhuijsen, Johannes F.
    Oyen, Wim J. G.
    Mulders, Peter F. A.
    EUROPEAN UROLOGY, 2013, 63 (06) : 1101 - 1106
  • [45] Comparing molecular variations and outcomes in Hispanic and non-Hispanic patients with metastatic clear cell renal cell carcinoma (ccRCC).
    Choi, Sharon
    Bliamptis, John
    Panian, Justine
    Reid, Skylar
    O'Keefe, Thomas
    Lee, Suzanna
    Guram, Kripa
    Bagrodia, Aditya
    Derweesh, Ithaar
    Rose, Brent S.
    Mckay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 372 - 372
  • [46] Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
    Del Vecchio, Sharon J.
    Ellis, Robert J.
    JOURNAL OF KIDNEY CANCER AND VHL, 2018, 5 (04): : 1 - 5
  • [47] Results from phase 3 study of 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).
    Shuch, Brian M.
    Pantuck, Allan J.
    Bernhard, Jean-Christophe
    Morris, Michael A.
    Master, Viraj A.
    Scott, Andrew Mark
    Van Praet, Charles
    Bailly, Clement
    Aksoy, Tamer
    Merkx, Robin
    Schuster, David M.
    Lee, Sze Ting
    Pandit-Taskar, Neeta
    Fan, Alice C.
    Tauchmanova, Libuse
    Allman, Phillip
    Vadali, Kavita
    Hayward, Colin
    Mulders, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [48] Pharmacotherapy for treating metastatic clear cell renal cell carcinoma
    Porta, Camillo
    Chiellino, Silvia
    Ferrari, Alessandra
    Mariucci, Sara
    Liguigli, Wanda
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (02) : 205 - 216
  • [49] Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma
    Wentink, Madelon Q.
    Verheul, Henk M. W.
    Pal, Sumanta K.
    George, Saby
    Voortman, Johannes
    Danchaivijitr, Pongwut
    Adelaiye, Remi
    Poslinski, Diane
    Groman, Adrienne
    Hutson, Alan
    Pili, Roberto
    CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : E1 - E9
  • [50] Resolution on the results of the Expert Council on the treatment of advanced and metastatic clear cell renal cell carcinoma
    Alekseev, B. Ya.
    Atduev, V. A.
    Volkova, M. I.
    Gafanov, R. A.
    Zyryanov, A. V.
    Kalpinskiy, A. S.
    Karlov, P. A.
    Karyakin, O. B.
    Matveev, V. B.
    Nosov, D. A.
    Shirokorad, V. I.
    Usynin, Ye. A.
    Popov, A. M.
    ONKOUROLOGIYA, 2019, 15 (02): : 150 - 153
12345